000 01314 a2200385 4500
005 20250517233101.0
264 0 _c20181127
008 201811s 0 0 eng d
022 _a1476-5829
024 7 _a10.1111/vco.12433
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHarding, K
245 0 0 _aResponse rate to a single dose of vinblastine administered to dogs with treatment-naive multicentric lymphoma.
_h[electronic resource]
260 _bVeterinary and comparative oncology
_cDec 2018
300 _a636-641 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents, Phytogenic
_xadministration & dosage
650 0 4 _aDog Diseases
_xdrug therapy
650 0 4 _aDogs
650 0 4 _aFemale
650 0 4 _aLymphoma
_xdrug therapy
650 0 4 _aMale
650 0 4 _aTreatment Outcome
650 0 4 _aVincristine
_xadministration & dosage
700 1 _aBergman, N
700 1 _aSmith, A
700 1 _aLindley, S
700 1 _aSzivek, A
700 1 _aMilner, R
700 1 _aBrawner, W
700 1 _aLejeune, A
773 0 _tVeterinary and comparative oncology
_gvol. 16
_gno. 4
_gp. 636-641
856 4 0 _uhttps://doi.org/10.1111/vco.12433
_zAvailable from publisher's website
999 _c28739313
_d28739313